Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Receivables: 2010-2024

Historic Receivables for Cross Country Healthcare (CCRN) over the last 15 years, with FY2024 value amounting to $283.6 million.

  • Cross Country Healthcare's Receivables fell 2594.64% to $231.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.4 million, marking a year-over-year decrease of 2594.64%. This contributed to the annual value of $283.6 million for FY2024, which is 3864.0% down from last year.
  • Per Cross Country Healthcare's latest filing, its Receivables stood at $283.6 million for FY2024, which was down 3864.0% from $462.3 million recorded in FY2023.
  • Cross Country Healthcare's 5-year Receivables high stood at $649.0 million for FY2022, and its period low was $218.3 million during FY2020.
  • Moreover, its 5-year median value for Receivables was $462.3 million (2023), whereas its average is $449.4 million.
  • Its Receivables has fluctuated over the past 5 years, first surged by 19038.08% in 2021, then tumbled by 3864.0% in 2024.
  • Cross Country Healthcare's Receivables (Annual) stood at $218.3 million in 2020, then skyrocketed by 190.38% to $633.9 million in 2021, then grew by 2.39% to $649.0 million in 2022, then dropped by 28.78% to $462.3 million in 2023, then crashed by 38.64% to $283.6 million in 2024.
  • Its Receivables stands at $283.6 million for FY2024, versus $462.3 million for FY2023 and $649.0 million for FY2022.